New Delhi [India], September 24 (ANI): Indian Council of Medical Research (ICMR)-COVID-19 National Task Force Joint Monitoring Group dropped the usage of Ivermectin and Hydroxychloroquine (HCQ) drugs from revised clinical guidelines for the management of adult COVID-19 patients. However, the new guidelines mention the use of Remdesivir and Tocilizumab in specific circumstances. Among the key guidelines which are routinely stressed include--wearing masks, physical distancing and hand hygiene. Suggesting a moderate use of other drugs like Remedesivir, the guideline advises the former to be used only in select moderate or severe Covid-19 patients on supplemental oxygen within 10 days of onset...